Skincure Oncology Financing
Skincure Oncology Llc, Limited Liability Company just submitted form D for $4.00 million equity and debt financing. This is a new filing. Skincure Oncology was able to sell $1.10 million so far. That is 27.50% of the round of financing. The total private offering amount was $4.00 million. This form was filed on 2016-10-05. The reason for the financing was: unspecified. The fundraising still has about $2.90 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Skincure Oncology is based in Georgia. The filler’s business is not disclosed. The SEC form was submitted by KERWIN BRANDT MANAGER. The company was incorporated in 2016. The filler’s address is: 8770 W. Bryn Mawr Avenue, Suite 1370, Chicago, Il, Illinois, 60631. Kerwin Brandt is the related person in the form and it has address: 8770 W. Bryn Mawr Avenue, Suite 1370, Chicago, Il, Illinois, 60631. Link to Skincure Oncology Filing: 000168613216000001.
Analysis of Skincure Oncology Offering
On average, firms in the not disclosed sector, sell 67.77% of the total offering amount. Skincure Oncology sold 27.50% of the offering. The financing is still open. The average financing size for companies in all industries in our database is $3.05 million. The offering was 63.93% smaller than the average of $3.05 million. Of course this should not be taken as negative. Firms raise funds for a variety of reasons and needs. The minimum investment for this fundraising was set at $50000. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Skincure Oncology Also
The Form D signed by KERWIN BRANDT might help Skincure Oncology Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.